| Revenue | DKK -26K | +415% |
| EBITDA | DKK -26K | -415% |
| Net profit | DKK -27K | -405% |
| Total assets | DKK 161K | -22% |
| Equity | DKK 129K | -33% |
| Employees | 3 | — |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 490 | -3 | -4 | -4 | -4 | -4 | -5 | -5 | -26 |
| Staff expenses | -486 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 4 | -3 | -4 | -4 | -4 | -4 | -5 | -5 | -26 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 4 | -3 | -4 | -4 | -4 | -4 | -5 | -5 | -26 |
| Net financials | 0 | 0 | -0 | -0 | -0 | -1 | -2 | -0 | -1 |
| Profit before tax | 4 | -3 | -4 | -4 | -4 | -5 | -7 | -5 | -27 |
| Tax | 1 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 |
| Net profit | 2 | -3 | -4 | -3 | -4 | -5 | -7 | -5 | -27 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 443 | 219 | 222 | 218 | 218 | 481 | 207 | 207 | 161 |
| Equity | 187 | 195 | 215 | 212 | 208 | 203 | 196 | 191 | 129 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 256 | 24 | 6 | 6 | 10 | 278 | 10 | 16 | 32 |
| Total debt | 256 | 24 | 6 | 6 | 10 | 278 | 10 | 16 | 32 |
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25.0% | 25.0% | 2024 | |
| Individual | 25.0% | 25.0% | 2024 | |
Speciallæge Pierre Schydlowsky Holding ApS | Company | 15.0% | 15.0% | 2024 |
SPECIALLÆGE FINN JOHANNSEN ApS | Company | 15.0% | 15.0% | 2024 |
| Individual | 5.0% | 5.0% | 2024 | |
| Individual | 10.0% | 10.0% | 2016 | |
Injurymap ApS | Company | 15.0% | 15.0% | 2022 |
| Person | Role here | Other companies |
|---|